Novo Holdings to take a 25% share in Envirotainer

Novo Holdings has agreed to acquire a 24.9% equity stake in Envirotainer in partnership with private equity firm Cinven.
Cinven had previously announced the acquisition of Envirotainer in July this year.
Samir Kamal, a senior director at Novo Holdings, confirmed: “Envirotainer is a very attractive investment opportunity for Novo Holdings.
“The company is a leading player and is in an excellent position to further benefit from the increasingly important demand for temperature-controlled biopharma logistics.”
Meanwhile, Michael Berg, Envirotainer’s chief executive, said: “We see great value from Novo Holdings’ healthcare expertise and pharmaceutical market knowledge to further develop the customer service offering of Envirotainer.”
Novo Holdings is the holding company of the Novo Group. A fully owned subsidiary of the Novo Nordisk Foundation, at the end of 2017 it fully or partly owned more than 80 life science companies,
Stockholm-headquartered Envirotainer designs, manufactures and leases out active temperature-controlled containers used primarily for moving biopharma products by air.
It has approximately 600 customers worldwide, including many of the globally active biopharma companies, and has a portfolio of more than 5,800 leased containers in use around the world.
According to a Novo Holdings statement, Envirotainer presents an investment opportunity because of:

  • Its market leadership. Novo Holdings considers that Envirotainer is a leading player in the pharma airfreight segment, with an innovative product offering, consistent service delivery and global delivery capability
  • The attractive market. The rise in biopharma sales for a broad range of clinical treatments, in combination with tightening regulatory requirements for transporting these products, is understood to be driving strong growth in Envirotainer’s markets
  • Global growth. Cinven and Novo Holdings will support Envirotainer’s global growth by developing its technology and expanding its container fleet and global service network

Read more Pharma Logistics news
Read more ULD news

Share this story